Conventional PRP is powerful but unpredictable. PLA-REGEN turns it into a standardized, ready-to-use product with a defined growth-factor profile — the same biology, finally to a reproducible standard.
Platelet-rich plasma works. The problem is you never quite know what you’re getting.
Every PRP prep is different — patient to patient, spin to spin, clinic to clinic. Clinicians have lived with that variability for years because the underlying biology is too good to ignore. PLA-REGEN changes the equation.
One kit. A defined output. Every time.
Built on Plasfer’s Platelet Transfer Technology, PLA-REGEN is a standardized, GMP-grade platelet preparation delivered as a single, ready-to-use kit — with a defined growth-factor profile that conventional PRP simply cannot reproduce.
The near-term engine
Aesthetics first. Then orthopaedics, ophthalmology, wound care. PLA-REGEN is Plasfer’s commercial engine — the programme that generates value today and funds the oncology pipeline of tomorrow.
“We’re not reinventing the biology — we’re making it reliable. That’s what turns a promising procedure into a real product.” — Marco Malvestiti, CEO
PLA-REGEN is under development and not yet CE-marked. Its regulatory classification is being defined with the competent authorities. No claims of safety, efficacy or approval are made.